Emblation will be attending Europe’s largest podiatry conference from the 17th – 19th November at Glasgow’s SECC.
Emblation’s CEO, Gary Beale, will be joining our team for the duration of the 3 day conference to answer any questions about Swift’s pioneering technology. We will also be joined by experienced Swift users, who will be sharing their experiences about the treatment and our Marketing Director, Jonathan Williamson, will be on hand to discuss how Emblation can support Swift clinics to market this revolutionary treatment. Continue reading
Emblation have been shortlisted for the British Small Business award for ‘Innovation of the Year’.
The awards provide recognition to small companies for their achievements and their significant contributions to the British economy. These awards showcase a wealth of accomplishments from companies within a diverse range of sectors and highlight the achievements of British sole traders and small businesses.
Emblation will be exhibiting at the 2016 FIP World Congress of Podiatry, 26th -28th May, in Montreal, Canada.
This event, which is held every three years, is the largest gathering of international foot and ankle practitioners/specialists and provides professionals, industry and academia practicing within this field with the opportunity to connect. Continue reading
Emblation will be officially launching Swift at the College of Podiatry Annual Conference, 19th – 21st November in Harrogate.
The College of Podiatry Annual Conference is the largest professional podiatry event in Europe, with over 1,500 senior podiatrists attending the event. Continue reading
Emblation will be exhibiting at Medica from the 16th – 19th November in Düsseldorf, Germany.
With over 128,000 professional visitors from over the world, Medica is the world’s largest medical trade fair. Continue reading
Emblation is pleased to be attending the British Association of Dermatologists’ Annual Meeting, held from the 7th – 9th of July 2015 at Manchester Central, Manchester, UK.
The event will host a wide range of presentations from experts in various areas of dermatology, including a public lecture from Dr Christian Jessen on ‘Manifestations of Skin Problems’.
Dr Ivan Bristow – the UK’s leading authority on podiatric dermatology – will be conducting a two-day seminar on the 19th and 20th of June, 2015 at the Rosseau Muskoka Resort and Spa in Ontario, Canada – concerning recent developments in podiatric dermatology, as well as introducing dermoscopy as a new aid in the diagnosis of skin lesions.
Emblation will be exhibiting at the Australasian Podiatry Conference held between the 6-8 May 2015 at the Gold Coast Convention and Exhibition Center in Broadbeach, Queensland, Australia.
We are delighted to be exhibiting at Arab Health 2015 at the Dubai International Convention and Exhibition Center, from the 26th-29th of January 2015.
An annual event, Arab Health is the largest medical congress exhibition in the Middle East and the second largest in the world. 4,000 exhibitors from many aspects of the healthcare industry – including medical devices, hospital services and many more – will be in attendance, as well as over 11,000 delegates from across the globe.
We will be at Stand Z4D10 in the Scottish Pavilion, where the team will showcase our medical product development capabilities – Emblation’s fully 60601 compliant OEM systems have a wide range of customization options including frequency and power, and our experts can design and manufacture custom probes for many different applications.
The team will also be on hand to talk about the benefits of microwave ablation in various medical disciplines, as well as to answer any other questions.
To find out more about the conference, or register to attend, visit the website.
Emblation will be exhibiting at this year’s Medical Design & Manufacturing (MD&M) Minneapolis Conference and Exhibition, hosted at the Minneapolis Convention Center between the 29th and 30th of October 2014. MD&M Minneapolis is one of the leading exhibitions in the medical device industry calendar, attracting med-tech executives, researchers, bio-medical engineers and regulatory professionals from the mid-west and beyond.